Bionano Genomics (BNGO) FCF Margin (2017 - 2026)

Bionano Genomics has disclosed FCF Margin across 10 years of filings, most recently posting 85.48% for Q1 2026.

• FCF Margin for Q1 2026 came in at 85.48%, down 4267.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 67.15% (up 8614.0% YoY), and the FY2025 annual result was 57.33%, up 16695.0% from the prior year.
• FCF Margin came in at 85.48% for Q1 2026 at Bionano Genomics, down from 52.13% in the prior quarter.
• In the past five years, FCF Margin ranged from a high of 42.81% in Q1 2025 to a low of 585.08% in Q1 2022.
• The 5-year median for FCF Margin is 284.71% (2023), against an average of 263.04%.
• Across the five-year window, FCF Margin plunged 14619 bps in 2022 and jumped 27829 bps in 2025, its largest moves.
• Bionano Genomics' FCF Margin stood at 410.83% in 2022, then surged by 31 bps to 284.71% in 2023, then soared by 72 bps to 79.68% in 2024, then surged by 35 bps to 52.13% in 2025, then plunged by 64 bps to 85.48% in 2026.
• The last three FCF Margin figures came in at 85.48% (Q1 2026), 52.13% (Q4 2025), and 80.09% (Q3 2025), per Business Quant data.